|Year : 2014 | Volume
| Issue : 2 | Page : 196-203
Bacterial and fungal keratitis in Upper Egypt: In vitro screening of enzymes, toxins and antifungal activity
Abdullah A Gharamah1, Ahmed M Moharram2, Mady A Ismail2, Ashraf K AL-Hussaini3
1 School of Biological Sciences, Universiti Sains Malaysia, 11800 Minden, Pinang, Malaysia
2 Department of Botany, Faculty of Sciences, Assiut University, Assiut, Egypt
3 Department of Ophthalmology, Faculty of Medicine, Assiut University, Assiut, Egypt
|Date of Submission||20-May-2012|
|Date of Acceptance||06-Nov-2012|
|Date of Web Publication||11-Mar-2014|
Abdullah A Gharamah
School of Biological Sciences, Universiti Sains Malaysia, 11800 Minden, Pinang
Source of Support: The research is funded by assuit research university, Conflict of Interest: None
Purpose: This work was conducted to study the ability of bacterial and fungal isolates from keratitis cases in Upper Egypt to produce enzymes, toxins, and to test the isolated fungal species sensitivity to some therapeutic agents. Materials and Methods: One hundred and fifteen patients clinically diagnosed to have microbial keratitis were investigated. From these cases, 37 bacterial isolates and 25 fungal isolates were screened for their ability to produce extra-cellular enzymes in solid media. In addition, the ability of fungal isolates to produce mycotoxins and their sensitivity to 4 antifungal agents were tested. Results: Protease, lipase, hemolysins, urease, phosphatase, and catalase were detected respectively in 48.65%, 37.84%, 59.46%, 43.24%, 67.57%, and 100% out of 37 bacterial isolates tested. Out of 25 fungal isolates tested during the present study, 80% were positive for protease, 84% for lipase and urease, 28% for blood hemolysis, and 100% for phosphatase and catalase enzymes. Thirteen fungal isolates were able to produce detectable amounts of 7 mycotoxins in culture medium (aflatoxins (B1, B2, G1, and G2), sterigmatocystin, fumagillin, diacetoxyscirpenol, zearalenone, T-2 toxin, and trichodermin). Among the antifungal agents tested in this study, terbinafine showed the highest effect against most isolates in vitro. Conclusion: In conclusion, the ability of bacterial and fungal isolates to produce extracellular enzymes and toxins may be aid in the invasion and destruction of eye tissues, which, in turn, lead to vision loss.
Bacterial, extracellular enzymes, fungal, keratitis, toxins
|How to cite this article:|
Gharamah AA, Moharram AM, Ismail MA, AL-Hussaini AK.
Bacterial and fungal keratitis in Upper Egypt: In vitro screening of enzymes, toxins and antifungal activity. Indian J Ophthalmol 2014;62:196-203
|How to cite this URL:|
Gharamah AA, Moharram AM, Ismail MA, AL-Hussaini AK.
Bacterial and fungal keratitis in Upper Egypt: In vitro screening of enzymes, toxins and antifungal activity. Indian J Ophthalmol [serial online] 2014 [cited 2020 Apr 7];62:196-203. Available from: http://www.ijo.in/text.asp?2014/62/2/196/116463
Infectious keratitis (Corneal ulcer) is a common disease of the cornea, resulting in significant vision loss. It is caused by various organisms, such as bacteria, fungi, virus, or protozoa. The severity of corneal infections usually depends on the underlying condition of the cornea and the virulence of the infecting microbes.  In the developing world, corneal opacity accounts for approximately 15% of treatable blindness, second only to cataract.  A significant proportion of these opacities is secondary to infectious keratitis.  Unfortunately, in the developing world, treatment of these visually disabling infections is often delayed for several weeks or more, and patients commonly present with very advanced keratitis. This type of ulceration is commonly associated with ocular trauma, mainly plant trauma, followed by post-operative infections. ,
Ocular infections probably occur due to an interaction between various agents (bacteria and/or fungi), host (tissue and immunological mechanisms), and other factors.  For example, protease enzymes have been identified as a major pathogenic factor in Serratia keratitis.  Invasiveness of a fungal strain is aided by certain properties such as the capacity to adhere to the cells, to produce enzymes that destroy anatomical defenses and anti-microbial proteins, to survive and evade host defense mechanisms.  The secretion of enzymes such as phospholipase, protease, pseudocollagenase, and exotoxins causes coagulative necrosis with the loss of keratocytes and disruption of collagen lamellae.  Treatment of ocular fungal infections remains problematic, in part because of the expanding list of fungal pathogens and in other part because of the relatively short list of available therapeutic agents.  In treating ophthalmic mycoses, the ultimate aim is to preserve vision, and this depends on rapid diagnosis and efficient administration of appropriate antifungal therapy.  Due to the lack of information about keratitis in Upper Egypt and how the infectious agents can invade the eye, this work was designed to investigate the ability of bacterial and fungal species associated with keratitis to produce enzymes, toxins, and to test the activity of some antifungal agents.
| Materials and Methods|| |
A total of 115 patients clinically diagnosed to have microbial keratitis (microbial corneal ulcers) were investigated. All patients were admitted and treated in the department of ophthalmology of Assiut University Hospital, and their informed consent for corneal scrapings was obtained. Patients were from different areas of Upper Egypt. The patients were thoroughly examined using slit-lamp biomicroscope by an ophthalmologist. From each keatitis case, corneal scrapings were sent for direct microscopic examination and cultures. Bacterial and fungal isolates were identified by standard microbiological methods. ,
Thirty-seven bacterial isolates and 25 fungal isolates obtained were screened for their ability to produce extracellular enzymes in solid media. Two-day old bacterial cultures grown on nutrient agar plates while seven-day old cultures of fungi grown on Sabouraud dextrose agar plates were used for inoculation. All of these isolates were assigned numbers. The ability of these organisms to produce enzymes was measured by the clear zone around the colony/mm (protease), the depth of visible precipitate/mm (lipase), the color intensity (urease), the color zone around the colony/mm (phosphatase), and O 2 bubbles evolution (catalase).  The following substrates were used: Casein for protease, Tween 80 for lipase, 2% urea solution for urease, diphosphophenolphthalein for phosphatase, and 10% hydrogen peroxide solution for catalase. For blood hemolysis, the appearance of a hemolytic zone around the colony was considered as a positive result. The tested fungi were incubated 7 days at 37°C. Hemolysis was recorded as α-hemolysis (partial blood hemolysis), β-hemolysis (complete blood hemolysis), and γ-hemolysis (no hemolysis). Three replicates were used for each isolates in each enzyme test. Enzyme index was calculated according to method described by Ismail,  when possible.
An inoculum of each of 25 fungal isolates was transferred to 250 ml flasks, containing 50 ml potato dextrose broth. Three replicates were used, and the flasks were incubated at 28°C for 10 days as static culture. After the incubation period, the content of each flask (medium + mycelium) was transferred into a blender jar and homogenized for 2 minutes at low speed and 5 minutes in a high-speed blender (16000 rpm) with 50 ml chloroform. The extraction procedure was repeated again with the same volume of chloroform. The combined chloroform extracts were washed with equal volume of distilled water, filtered, dried over anhydrous sodium sulfate, and then evaporated to near dryness by flash evaporator. 
The dry crude extract was suspended in 50 ml chloroform and applied to a silica gel column (200 mesh, Merck) according to the method of AOAC.  The column was washed with 150 ml n-hexane followed by diethyl ether, and toxins were eluted with 200 ml of chloroform-acetone (9:1 v/v) solvents system. The elute was collected and evaporated to near dryness on a steam bath. The residue was diluted with chloroform to 1 ml.
The thin-layer chromatographic (TLC) technique was applied for semi-quantitative analysis of mycotoxins.  A Silica gel plate type 60 F 254 of about 0.3 mm thickness was used. The samples to be analyzed were applied as 50 μl solution in chloroform. The spots were dried during application with a flow of cold air. The plates were developed in developing tanks of 15 Χ 30 Χ 30 x cm diameter (Zeiss, Jena, Germany) saturated with solvent vapor. Each sample was chromatographed in two series in selective solvent system. When the front of the system reaches a height of about 15 cm above the origin, the development was interrupted; the chromatogram was dried in air and then examined for the presence of mycotoxins. The developed plates were detected before and after spraying with the different reagents using short wave (254 nm) and long wave UV light (356 nm).
The disc susceptibility test  was employed using filter paper discs fully saturated with the antifungal agent (~10 μl). The antifungal activity of 4 types of anti-fungal therapeutic agents (amphotericin B (50 mg), cetrimide (100 mg), ketoconazole (200 mg), and terbinafine (250 mg)) against 25 fungal isolates of keratitis origin were tested using 3 concentrations (0.1%, 0.5%, and 1%), which are similar or nearby the used concentrations in treatment. Additional concentration of amphotericin B (0.005) was used because it is the applicable concentration that is used for severe eye infection. Discs were placed on the surface of Sabouraud dextrose agar seeded with the test organism. Cultures were incubated at 28°C for 48 hours, after which the zone of inhibition of fungal growth around discs was measured in mm, and the data were recorded as the mean of 3 replicates. Dimethyl sulfoxide (DMSO) was used to dissolve the antifungal agents and also as a control in this test because it showed no effect on the organisms tested.
| Results|| |
The ability of 37 bacterial isolates to produce some extracellular enzymes and blood hemolysis were shown in [Table 1] and [Figure 1].
|Table 1: Extracellular enzymes and blood hemolysis produced by 37 bacterial isolates of keratitis origin*|
Click here to view
|Figure 1: Extracellular enzymes and blood hemolysis produced by 37 bacterial isolates of keratitis origin|
Click here to view
Protease was detected only in 18 out of 37 isolates tested. Two of these had enzyme index (PI) exceeding 2.4, and these were Micrococcus luteus and Staphylococcus sp. The other bacterial isolates had enzyme index ranging from 1.32 to 1.89. For lipase, only 14 showed positive capabilities of producing lipase, of which 7 isolates had at least a mean depth of precipitate of 6 mm. When testing the 37 bacterial isolates for hemolysis on human blood agar, 22 showed complete blood hemolysis (β- hemolysis). Regarding urease enzyme, out of 16 positive isolates, 2 were strong, 6 were moderate, and 8 were weak enzyme producers. For phosphatase enzyme, 25 isolates showed positive capabilities of producing phosphatase enzyme. Of these, 10 were strong, 5 were moderate, and 9 were weak producers. All 37 isolates tested could produce catalase enzyme. Of these, 30 were strong and 7 were moderate producers.
The ability of 25 fungal isolates from keratitis cases to produce some extracellular enzymes and blood hemolysis were shown in [Table 2] and [Figure 2].
|Figure 2: Extracellular enzymes and blood hemolysis produced by 25 fungal isolates of keratitis origin|
Click here to view
|Table 2: Extracellular enzymes and blood hemolysis produced by 25 fungal isolates of kiratitis origin*|
Click here to view
Protease was detected in 20 out of 25 isolates tested. Three of these had enzyme index (PI) more than 1.75, and these were Cladosporium cladosporioides (Fungal isolate (FI) No. 3955) and Candida sp. (FI No. 3958, 3959). The other fungal isolates had enzyme index ranging from 1.01 to 1. 14. For lipase, 21 out of 25 isolates showed positive capabilities of producing the enzyme, of which 6 isolates had a mean depth of precipitate ≥20 mm, and these were Aspergillus flavus (3 isolates), Cochliobolus spicifer, Fusarium solani, and F. verticillioides (1 isolate each). The other fungal isolates had a mean depth of precipitate less than 20 mm. Regarding urease enzyme, out of 21 positive isolates, 8 were strong producer and had enzyme index (UI) of more than 2. The others fungal isolates had enzyme index of less than 2. When testing hemolysis of human blood on agar medium, only 7 out of 25 isolates were positive and showed complete hemolysis (β-hemolysis). These were related to A. flavus (5 isolates), C. spicifer, and F. verticillioides (1 isolates each). With respect to phosphatase enzyme, the 25 fungal isolates tested were positive. Of these, 17 isolates were strong producers and 8 were weak. For catalase, the 25 fungal isolates tested could produce catalase, of which 14 were strong, 8 were moderate, and 3 were weak producers.
Of 25 fungal isolates tested for toxin production, only 13 were able to produce detectable amounts of toxins in culture medium [Table 3].
Seven mycotoxin types were detected, and these were aflatoxins (B1, B2, G1, and G2), sterigmatocystin, fumagillin, diacetoxyscirpenol, zearalenone, T-2 toxin, and trichodermin. Aflatoxins (B1, B2, G1, and/or G2) were produced by 5 isolates of Aspergillus flavus and 1 isolate of A. terreus. Two isolates of A. flavus produced high aflatoxin B1 Level (>500 mg/50 ml medium) while the other isolates produced either moderate or low levels of aflatoxins. Sterigmatocystin was produced by 2 isolates of A. fumigatus and 1 isolate of Penicillium chrysogenum. Fumagillin was produced only by one isolate of A. terreus. Diacetoxyscirpenol was produced in moderate amount by Fusarium oxysporum and F. solani (one isolates each). Zearalenone was produced at high level by only 1 isolate of F. solani. T-2 toxin was produced in low amount by only 1 isolate of F. verticillioides. Trichodermin was produced in low amount by 1 isolate of Trichoderma hamatum.
Twenty-five fungal isolates of keratitis origin were tested in vitro against 4 antifungal therapeutic agents. [Table 4].
|Table 4: In vitro antifungal activity of some antifungal theraputic agents*|
Click here to view
The minimal inhibitory concentration (MIC) of amphotericin B for Aspergillus flavus (FI No. 3939, 3940, 3941, 3942, 3943), A. niger (3950), Cladosporium cladosporioides (3955, 3956), Candida sp. (3959), Penicillium chrysogeum (3965), and sterile mycelia (3954) was at 0.1% concentration, while MIC for A. flavus (3945) and A. fumigatus (3947) was at 0.5% concentration. However, amphotercin B has no antifungal effect at all concentrations used on A. flavus (3944, 3946), the 3 A. terreus isolates tested, Candida sp. (3958), the 3 Fusarium species, and Trichoderma hamatum tested. Amphotericin B at 0.005% concentration was only active against Cochliobolus spicifer.
Cetyltrimethyl-ammonium bromide (citrimide) at 1% concentration was effective against all isolates except one (F. verticillioides no. 3963) while 0.5% was effective against 17 out of 25 isolates tested, and the latter concentration could be considered as the minimal inhibitory concentration for these 17 isolates where all of them showed no capabilities of growth at the lower (0.1%) concentration. Cetyltrimethyl-ammonium bromide at 1% concentration showed high activity against A.terreus (the 3 isolates tested) and Cochliobolus spicifer. On the other hand, cetyltrimethyl-ammonium bromide at 0.1% concentration has no effect on all isolates tested.
Ketoconazole at 1% and 0.5% concentrations was effective against all fungal isolates, except the 3 Fusarium species tested. However, 0.1% concentration was effective against only 9 isolates. The MIC of ketoconazole for A. flavus (FI No. 3941, 3942, 3945), A. fumigatus, the 3 A. terreus isolates, A. niger, C. cladsporioides (3955), P. chrysogenum, sterile mycelia, and T. hamatum was at 0.5% concentration.
Terbinafine at 1% and 0.5% concentrations was effective against all isolates except Candida sp. (3959) and Fusarium solani. On the other hand, terbinafine at 0.1% concentration was effective against 20 out of the 25 isolates tested. From the results shown in [Table 4], it could conclude that the MIC of terbinafine could only be determined for two isolates; Candida sp. (3958) and sterile mycelia at 0.5% concentration where it had high effect against most isolates at the 3 concentrations used.
| Discussion|| |
Since enzymes are important chemical weapons aiding the pathogen to invade host tissue, it was essential to shed some lights on the ability of some bacterial and fungal species isolated from keratitis cases to produce these compounds.
Protease, lipase, hemolysins, urease, phosphatase, and catalase were detected respectively in 48.65%, 37.84%, 59.46%, 43.24%, 67.57%, and 100% out of 37 bacterial isolates tested. The ocular inflammatory response to bacterial infection was suggested to be multifactorial and involved many different bacterial and host-derived factors.  Their study demonstrated that alpha, beta hemolysin, and lipase play a role in the ocular response and in the induction of clinical inflammation and infiltration of inflammatory cells. Moreover, Liesegang  reported that bacterial proteases attack peptide bonds, dissolve elastin, and acts as non-specific collagenases in vitro. He added that Staphylococcus aureus and other coagulase-positive strains are the most pathogenic and elaborate extracellular enzymes such as lipase, coagulase, staphylokinase, hyaluronidase, DNase, and lysozyme. Isolates of S. aureus showed different capabilities of producing different enzymes tested in this work; however, all produced β-hemolysin and catalase. S. aureus products such as lipoteichoic acid, peptidoglycan and alpha toxin have shown in cell culture to induce the expression of pro-inflammatory cytokines and adhesion molecules, which lead to the infiltration of inflammatory cells.  Pseudomonas aeruginosa ich produced protease, lipase, β-hemolysin, urease, phosphatase, and catalase was also reported by Hobden, to produce a multitude of secreted proteases and toxins that can be considered virulence factors for the eye. Of the 37 bacterial isolates in vitro tested during this study, some isolates were strong enzyme producers of urease (2 isolates) and catalase (30). In this respect, Cejkova et al.  studied catalase activity in the corneas of normal rabbit eyes of various age and found that the corneas of young and particularly aged rabbits might be more susceptible to oxidation injury as compared to the corneas of young adult animals.
Out of 25 fungal isolates tested during the present study, 80% were positive for protease, 84% for lipase and urease, 28% for blood hemolysis, and 100% for phosphatase and catalase enzymes. According to Gopinathan et al.,  the capability of fungal corneal pathogens to utilize collagen in vitro supports the assumption that the ability of a fungus to elicit corneal tissue damage is dependent, at least in part, on the utilization of corneal collagen in vivo by the infecting agent. Zhu et al.  had also identified extracellular proteases in cultures with collagen (in vitro) of a corneal isolate of A. flavus and concluded that the collagenase activity is a mediator of the severe corneal destruction caused by this isolate. Moreover, Dorner  reported that the secretion of enzymes and exotoxins causes coagulative necrosis with the loss of keratocytes and disruption of collagen lamellae.
Mycotoxins are low molecular weight fungal products that may be toxic to higher organisms. Only a few studies have investigated the role of fungal toxins as contributing factors in eye infections. In harmony with our results, Raza et al.  found that isolates of Fusarium species from 18 pateints with keratomycosis could produce mycotoxins in vitro. Of these isolates, 13 produced nivalenol, 6 produced deoxynivalenol, 9 gave T-2 toxin, and 2 showed the presence of diacetoxyscirpenol at different intervals. These authors were postulated that the virulence of Fusarium for the cornea might be partly related to its ability to produce mycotoxins. However, Thomas  found that some isolates of Fusarium from fungal keratitis produce various toxins, but it was difficult to correlate the production of toxins with the manifestation and progress of the disease.
The in vitro sensitivity test using different antifungal agents is greatly recommended to choose the most effective drug for therapy.
The minimal inhibitory concentration (MIC) of amphotericin B was at 0.1% or 0.5% concentrations for most fungal species tested while there was no effect on Aspergillus terreus, the 3 Fusarium species, and Trichoderma hamatum. Amphotericin B in solution or as an ointment has been used topically to treat keratitis; it is the treatment of choice for keratitis due to Candida species as reported by Tanure et al.  However, only 1 isolate of Candida (out of two tested in the present study) was affected when amphotericin B was used at 1%, 0.5%, and 0.1% concentrations. Amphotericin B was also used for treatment of 3 patients with keratitis and hypopyon due to A. flavus with minimal toxicity.  This is in harmony with our results in vitro on 6 out of 8 A. flavus isolates where they were inhibited mostly at 1%, 0.5%, and 0.1% concentrations of amphotericin B. Amphotericin B has a broad-spectrum of action including many Aspergillus species, Candida species, and Penicillium marneffei while Aspergillus terreus and Fusarium species are often resistant. 
Cetyltrimethyl ammonium bromide at 1% was more effective than 0.5% and 0.1% against all isolates tested except F. verticillioides. In agreement with our result in vitro on F. salani of keratitis origin, Mahmoud  reported that MIC of cetyltrimethyl ammonium bromide was 100 μg/ml, and he added that it had no pathological effect to eye corneal tissues and with no side effects during the treatment course of a rabbit model with keratitis.
Ketoconazole at 1% and 0.5% concentrations was effective against all fungal isolates, except the 3 Fusarium species tested. Marangon et al. studied ketoconazole activity against species of Aspergillus (4 isolates), Candida (20), and Fusarium (9) and found that MIC values were 4, 0.032, and >16 μg/ml, respectively. In accordance with our findings, Al-Hussaini et al.  treated successfully 85% of mycotic keratitis cases in Upper Egypt with topical ketoconazole.
Terbinafine at the 3 concentrations used (1%, 0.5%, and 0.1%) showed high activity against most isolates tested, and this revealed that terbinafine was more effective in vitro than the other 3 antifungal therapeutic agents used in this study. In accordance with our results on all isolates of Aspergilli (16 of 4 species) and 1 out of 2 isolates of Candida sp., Richardson and Warnock  reported that terbinafine is active against Aspergillus species, Candida albicans, and some other Candida species. Terbinafine has a brood-spectrum and is considered a fungicidal in vitro, whereas the azoles (e.g., ketoconazole) are primarily fungistatic, and this may partially account for the greater efficacy of terbinafine. 
The present study showed the ability of bacterial and fungal isolates to produce extracellular enzymes and mycotoxins, which consider as contributing factors to invade the eye's tissues, and this can explain the severity of corneal infections. Thus, seeking for an efficient therapy is important in Upper Egypt where most of people are working in agriculture, which makes them more predisposing to keratitis through plant trauma.
| Acknowledgement|| |
We thank all the members of Ophthalmology Department and Assuit University Mycological center (AUMC) for assistance in samples collection and identification.
| References|| |
Ahn M, Yoon K, Ryu S, Cho N, You I. Clinical Aspects and Prognosis of Mixed Microbial (Bacterial and Fungal) Keratitis. Cornea 2011;30:409-13.
WHO, World Health Organization. Causes of blindness and visual impairment. Available from: http://www. who.int/blindness/causes/en/index.html. (Last accessed on 2011 Nov 11).
Feilmeier MR, Sivaraman KR, Oliva M, Tabin GC, Gurung R. Etiologic Diagnosis of Corneal Ulceration at a Tertiary Eye Center in Kathmandu, Nepal. Cornea 2010;29:1380-5.
Thomas PA. Current Perspectives on Ophthalmic Mycoses. Clin Microbiol Rev 2003;16:730-97.
Liesegang TJ. Bacterial keratitis. In: Kaufman HE, Barron BA, McDonald, editors. The Cornea. 1 st
ed. Bosten: Butterworth-Heinemann; 1998. p. 159-211.
Thomas PA. Mycotic keratitis: An underestimated mycosis. J Med Vet Mycol 1994;32:235-54.
Dorner JW. Chromatographic analysis of mycotoxins. In: Shibamoto T, editor. Chromatographic analysis of environmental and food toxicants. 1 st
ed. New York: Marcel Dekker Inc.; 1998. p. 113-30.
Marangon FB, Miller D, Giaconi JA, Alfonso EC. In vitro
investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens. Am J Ophthalmol 2004;137:820-5.
Manzouri B, Vafidis GC, Wyse RK. Pharmacotherapy of fungal eye infections. Expert Opin Pharmacol 2001;2:1849-57.
De Hoog GS, Guarro J, Gene J, Figueras MJ. Atals of Clinical Fungi. 2 nd
ed. Netherland: Centraalburearu voor Schimmelcultures; 2000.
Ryan KJ, Ray CG, Sherris JC. Sherris Medical Microbiology. 4 th
ed. USA: McGraw-Hill Companies Inc.; 2004.
Paterson RR, Bridge PD. Biochemical techniques for filamentous fungi. Surrey: Int. Mycol. Instit. CAB International; 1994.
Collins GH, Lyne PM, Grange JM. Microbiological methods. 7 th
ed. Cambridge: Butterworth-Heinemann; 1995.
Ismail MA. Deterioration and spoilage of peanuts and desiccated coconuts from two sub-Saharan tropical East African countries due to the associated mycobiota and their degradative enzymes. Mycopathologia 2001;150:67-84.
Gonzalez Pereyra ML, Rosa CA, Dalcero AM, Cavaglieri LR. Mycobiota and mycotoxins in malted barley and brewer's spent grain from Argentinean breweries. Lett Appl Microbiol 2011;53:649-55.
AOAC. Official Methods of Analysis. 1 st
ed. Arlington: AOAC International; 1995.
Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, et al
. In vitro
susceptibility of invasive isolates of Candida
spp. to anidulafungin, caspofungin, and micafungin: Six years of global surveillance. J Clin Microbiol 2008;46:150-6.
Giese MJ, Berliner JA, Riesner A, Wagar EA, Mondino BJ. A comparison of the early inflammatory effects of an agar-/sar- versus a wild type strain of Staphylococcus aureus
in a rat model of endophthalmitis. Curr Eye Res 1999;18:177-85.
Henderson B, Wilson M. Cytokine induction by bacteria: Beyond lipopolysaccharide. Cytokine 1996;8:269-82.
Hobden JA. Pseudomonas aeruginosa
proteases and corneal virulence. DNA Cell Biol 2002;21:391-6.
Cejkova J, Vejrazka M, Platenik J, Stipek S. Age-related changes in superoxide dismutase, glutathione peroxidase, catalase and xanthine oxidoreductase/xanthine oxidase activities in the rabbit cornea. Exp Gerontol 2004;39:1537-43.
Gopinathan U, Ramakrishna T, Willcox M, Rao CM, Balasubramanian D, Kulkarni A, et al
. Enzymatic, clinical and histologic evaluation of corneal tissues in experimental fungal keratitis in rabbits. Exp Eye Res 2001;72:433-42.
Zhu WS, Wojdyla K, Donlon K, Thomas PA, Eberle HI. Extracellular proteases of Aspergillus flavus
. Diagn. Clin Microbiol Infect 1990;13:491-7.
Raza SK, Mallett AI, Howell SA, Thomas PA. An in vitro
study of the sterol content and toxin production of Fusarium
isolates from mycotic keratitis. J Med Microbiol 1994;41:204-8.
Tanure MA, Cohen EJ, Grewal S, Rapuano CJ, Laibson PR. Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea 2000;19:307-12.
Kaushik S, Ram J, Brar GS, Jain AK, Chakraborti A, Gupta A. Intracameral amphotericin B: Initial experience in severe keratomycosis. Cornea 2001;20:715-9.
Richardson MD, Warnock DW. Antifungal drugs. In: Fungal infection, diagnosis and management. 3 rd
ed. Oxford: Black Publishing Ltd.; 2003. p. 30-61.
Mahmoud YA. Efficacy of cetrimide as a promising antifungal agent against Fusarium solani
human corneal ulcer. Assiut Univ J Bot 2005;34:463-75.
AL-Hussaini MK, Abdel-Kader MI, Abu-Ghadeer AA, AL-Hussaini AK. Keratomycosis diagnosis and therapy with ketoconazole. Bull Ophthalmol Soc Egypt 1988;81:113-7.
Chhablani J. Fungal endophthalmitis. Expert Rev Anti Infect Ther 2011;9:1191-201.
[Figure 1], [Figure 2]
[Table 1], [Table 2], [Table 3], [Table 4]